Therapeutic responses to corticosteroids in Graves' ophthalmopathy

Journal of the Formosan Medical Association

Volumn 95, Issue 11, 1996, Pages 833-838

  Chang, Tien Chun ^a   Kao, Shine C S ^a   Hsiao, Yung Lien ^a   Lu, Chih Ping ^a   Huang, Kou Mou ^a   Tzeng, Shiaw Shen ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

corticosteroid therapy; glycosaminoglycan; Graves' disease; Graves' ophthalmopathy; orbital computed tomography; prognostic factors

Indexed keywords

CORTICOSTEROID; METHYLPREDNISOLONE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; DRUG EFFICACY; EYE DISEASE; FEMALE; GRAVES DISEASE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; PROGNOSIS;

ADRENAL CORTEX HORMONES; ADULT; FEMALE; GRAVES DISEASE; HUMANS; MALE; METHYLPREDNISOLONE; MIDDLE AGED; PREDNISOLONE; PROGNOSIS; VISUAL ACUITY;

EID: 0030479151     PISSN: 09296646     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Weetman AP: Auioimmunity in Graves' ophthalmopathy: a review. J R Soc Med 1989;82:153-8.
2. Kazim M, Trokel S, Moore S: Treatment of acute Graves orbkopathy. Ophthalmology 1991;98:1443-8.
3. Kendall-Taylor P, Crombie AL, Stephenson AM, et al: Intravenous methylprednisolone in the treatment of Graves' ophthalmopathy. Br Med J 1988;297:1574-8.
4. Weetman AP, McGregor AM, Ludgate M, et al: Cyclosporin improves Graves' ophthalmopathy. Lancet 1983;2:486-9.
5. Antonelli A, Saracino A, Alberti B, et al: High-dose intravenous immunoglobulin treatment in Graves' ophthalmopathy. Acta Endocrinol 1992;126:13-23.
6. Wiersinga WM, Smit T, Schuster-Uittenhoevee ALJ, et al: Therapeutic outcome of prednisolone medication and of orbital irradiation in patients with Graves' ophthalmopathy. Ophthalmologica 1988;197:75-84.
7. Kao SCS, Kendler DL, Nugent RA, et al: Radiotherapy in the management of thyroid orbitopathy: computed tomography and clinical outcomes. Arch Ophthalmol 1993;111:819-23.
8. Petersen IA, Kriss JP, McDougall IR, et al: Prognostic factors in the radiotherapy of Graves' ophthalmopathy. Int J Radiat Oncol Biol Phys 1990;19:259-64.
9. Mourits MPh, Koornneef L, Wiersinga WM, et al: Clinical criteria for the assessment of disease activity in Graves' ophthalmopathy: a novel approach. Br J Ophthalmol 1989;73:639-44.
10. Shorr N, Seiff SR: The four stages of surgical rehabilitation of lhe patient with dysthyroid ophthalmopathy. Ophthalmology 1986;93:476-83.
11. Kao SCS, Chang TC, Hou PK: Surgical management of Graves' ophthalmopathy: stage I, inferomedial orbital decompression. J Formas Med Assoc 1992;91:1154-61.
12. Burch HB, Wartofsky L: Graves' ophthalmopathy: current concepts regarding pathogenesis and management. Endocr Rev 1993;14:747-93.
13. Werner SC: Modification of the classification of the eye changes of Graves' disease: recommendations of the Ad Hoc Committee of the American Thyroid Association. J Clin Endocrinol Metab 1977;44:203-9.
14. Duke-Elder S, Smith RJH: The examination of the visual functions. In: Duke-Elder S, ed. The Foundations of Ophthalmology: Heredity, Pathology, Diagnosis, and Therapeutics. System of Ophthalmology. Vol 7. St Louis: CV Mosby, 1962:370-3.
15. Chang TC, Huang KM, Chang TJ, et al: Correlation of orbital computed tomography enlargement and antibodies in patients with hyperthyroid Graves' disease. Clin Endocrinol 1990;32:551-8.
16. Kahaly G, Schuler M, Sewell AC, et al: Urinary glycosaminoglycan in Graves' ophthalmopathy. Clin Endocrinol 1990;33:35-44.
17. Chang TC, Yao WC, Chang CC: Octreotide and urinary glycosaminoglycan in Graves' disease. Letter. Br Med J 1992;304:1444.
18. Prummel MF, Mourits MPh, Blank L, et al: Randomised double-blind trial of prednisolone versus radiotherapy in Graves' ophthalmopathy. Lancet 1994;342:949-54.
19. Chen YL, Chang TC, Huang KM, et al: Relationship of eye movement to computed tomographic findings in patients with Graves' ophthalmopathy. Acta Ophthalmol S cand 1994;72:472-7.